End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
187.5 TWD | -1.32% | +3.31% | -1.32% |
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company is one of the best yield companies with high dividend expectations.
- Sales forecast by analysts have been recently revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Most analysts recommend that the stock should be sold or reduced.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.32% | 294M | C | ||
+8.32% | 38.89B | B | ||
-5.87% | 17.87B | B- | ||
-16.61% | 2.37B | D+ | ||
-16.74% | 1.48B | C+ | ||
+32.16% | 1.24B | - | ||
-34.97% | 761M | - | ||
-34.91% | 738M | B- | ||
-7.58% | 672M | - | ||
+25.66% | 509M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 1565 Stock
- Ratings St.Shine Optical Co.,Ltd.